Potentially reduced exposure cigarettes accelerate atherosclerosis: Evidence for the role of nicotine

Cardiovascular Toxicology

Volumn 7, Issue 3, 2007, Pages 192-201

  Catanzaro, Daniel F ^a   Zhou, Ying ^a   Chen, Rong ^a   Yu, Fangmin ^a   Catanzaro, Sarah E ^a   De Lorenzo, Mariana S ^a   Subbaramaiah, Kotha ^a   Zhou, Xi Kathy ^a   Pratico, Domenico ^b   Dannenberg, Andrew J ^a   Weksler, Babette B ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Complete blood count; Cytochrome P450; Isoprostane; Oxidative stress; Sympathetic nervous system

Indexed keywords

APOLIPOPROTEIN E; CIGARETTE SMOKE; CYTOCHROME P450 1A1; ISOPROSTANE; NICOTINE; TAR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD CELL COUNT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; HEART RATE; LEUKOCYTE COUNT; MALE; MOUSE; MULTIPLE REGRESSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

ADMINISTRATION, INHALATION; ANIMALS; AORTA; APOLIPOPROTEINS E; AZO COMPOUNDS; COLORING AGENTS; CORONARY ARTERY DISEASE; COTININE; CYTOCHROME P-450 CYP1A1; GENE SILENCING; LUNG; MALE; MICE; MICE, KNOCKOUT; NICOTINE; OXIDATIVE STRESS; SMOKING; TARS; TOBACCO;

ANIMALIA; MUS; NICOTIANA TABACUM;

EID: 35348902500     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-007-0027-z     Document Type: Article

References (33)

1. Meckley, D. R., Hayes, J. R., Van Kampen, K. R., Ayres, P. H., Mosberg, A. T., & Swauger, J. E. (2004). Comparative study of smoke condensates from 1R4F cigarettes that burn tobacco versus ECLIPSE cigarettes that primarily heat tobacco in the SENCAR mouse dermal tumor promotion assay. Food and Chemical Toxicology, 42, 851-863.
2. Ambrose, J., & Barua, R. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: An update. Journal of The American College of Cardiology, 43, 1731-1737.
3. Kilaru, S., Frangos, S., Chen, A., Gortler, D., Dhadwal, A., Araim, O., & Sumpio, B. (2001). Nicotine: A review of its role in atherosclerosis. Journal of The American College of Surgeons, 193, 538-546.
4. Moskowitz, W. B., Mosteller, M., Schieken, R. M., Bossano, R., Hewitt, J. K., Bodurtha, J. N., & Segrest, J. P. (1990). Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study. Circulation, 81, 586-592.
5. Feldman, J., Shenker, I. R., Etzel, R. A., Spierto, F. W., Lilienfield, D. E., Nussbaum, M., & Jacobson, M. S. (1991). Passive smoking alters lipid profiles in adolescents. Pediatrics, 88, 259-264.
6. Bergmann, S., Siekmeier, R., Mix, C., & Jaross, W. (1998). Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respiratoires Physiology, 114, 269-275.
7. Penn, A., Batastini, G., Soloman, J., Burns, F., & Albert, R. (1981). Dose-dependent size increases of aortic lesions following chronic exposure to 7,12-dimethylbenz(a)anthracene. Cancer Research, 41, 588-592.
8. Batastini, G., & Penn, A. (1984). An ultrastructural comparison of carcinogen-associated and spontaneous aortic lesions in the cockerel. American Journal of Pathology, 114, 403-409.
9. Penn, A., & Snyder, C. (1988). Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis, 9, 2185-2189.
10. Albert, R. E., Vanderlaan, M., Burns, F. J., & Nishizumi, M. (1977). Effect of carcinogens on chicken atherosclerosis. Cancer Research, 37, 2232-2235.
11. Bond, J. A., Gown, A. M., Yang, H. L., Benditt, E. P., & Juchau, M. R. (1981). Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. Journal of Toxicology Environmental Health, 7, 327-335.
12. Curfs, D. M., Lutgens, E., Gijbels, M. J., Kockx, M. M., Daemen, M. J., & van Schooten, F. J. (2004). Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. American Journal of Pathology, 164, 101-108.
13. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arteriosclerosis and Thrombosis, 14, 133-140.
14. Gairola, C., Drawdy, M., Block, A., & Daugherty, A. (2001). Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E -/- mice. Atherosclerosis, 156, 49-55.
15. Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001). Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nature Medicine, 7, 833-839.
16. Catanzaro, D. F., Chen, R., Yan, Y., Hu, L., Sealey, J. E., & Laragh, J. H. (1999). Appropriate regulation of renin and blood pressure in 45 kb human renin/human angiotensinogen transgenic mice. Hypertension, 33, 318-322.
17. Hecht, S. S., Carmella, S. G., Chen, M., Dor Koch, J. F., Miller, A. T., Murphy, S. E., Jensen, J. A., Zimmerman, C. L., & Hatsukami, D. K. (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Research, 59, 590-596.
18. Ding, T., Yao, Y., & Pratico, D. (2005). Increase in peripheral oxidative stress during hypercholesterolemia is not reflected in the central nervous system: Evidence from two mouse models. Neurochemistry International, 46, 435-439.
19. Almahmeed, T., Boyle, J. O., Cohen, E. G., Carew, J. F., Du, B., Altorki, N. K., Kopelovich, L., Fang, J. L., Lazarus, P., Subbaramaiah, K., & Dannenberg, A. J. (2004). Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract. Carcinogenesis, 25, 793-799.
20. Morrow, J. (2005). Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arteriosclerosis Thrombosis and Vascular Biology, 25, 279-286.
21. Cai, H., Griendling, K., & Harrison, D. (2003). The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends in Pharmacological Sciences, 24, 471-478.
22. Madamanchi, N., Vendrov, A., & Runge, M. (2005). Oxidative stress and vascular disease. Arteriosclerosis Thrombosis and Vascular Biology, 25, 29-38.
23. Nebert, D., Roe, A., Dieter, M., Solis, W., Yang, Y., & Dalton, T. (2000). Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochemical Pharmacology, 59, 65-85.
24. Yan, Z., Subbaramaiah, K., Camilli, T., Zhang, F., Tanabe, T., McCaffrey, T., Dannenberg, A., & Weksler, B. (2000). Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-kappaB. Journal of Biological Chemistry, 275, 4949-4955.
25. Reddy, S., Finkelstein, E., Wong, P., Phung, A., Cross, C., & van der Vliet, A. (2002). Identification of glutathione modifications by cigarette smoke. Free Radical Biology and Medicine, 33, 1490-1498.
26. Tonnessen, B., Severson, S., Hurt, R., & Miller, V. (2000). Modulation of nitric-oxide synthase by nicotine. Journal of Pharmacology and Experimental Therapeutics, 295, 601-606.
27. Chalon, S., Moreno, H., Benowitz, N., Hoffman, B., & Blaschke, T. (2000). Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clinical Pharmacology & Therapeutics, 67, 391-397.
28. Kiowski, W., Linder, L., Stoschitzky, K., Pfisterer, M., Burckhardt, D., Burkart, F., & Buhler, F. R. (1994). Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation, 90, 27-34.
29. Benowitz, N. L. (1997). The role of nicotine in smoking-related cardiovascular disease. Preventive Medicine, 26, 412-417.
30. Jones, G. T., Jiang, F., McCormick, S. P., & Dusting, G. J. (2005). Elastic lamina defects are an early feature of aortic lesions in the apolipoprotein E knockout mouse. Journal of Vascular Research, 42, 237-246.
31. Murphy, S., Link, C., Jensen, J., Le, C., Puumala, S., Hecht, S., Carmella, S., Losey, L., & Hatsukami, D. (2004). A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiology Biomarkers & Prevention, 13, 1617-1623.
32. Lee, P. (1999). Uses and abuses of cotinine as a marker of tobacco smoke exposure. In J. Garrod & P. Jacob III (Eds.), Analytical determination of nicotine, cotinine and their related compounds and their metabolites. New York: Elsevier.
33. Djordjevic, M. V., Stellman, S. D., & Zang, E. (2000). Doses of nicotine and lung carcinogens delivered to cigarette smokers. Journal of The National Cancer Institute, 92, 106-111.